ART with long-term effects without immunosuppression

Published Date: 02 Mar 2023

The latest studies of long-acting ART show benefits even in people who are not immune. Meanwhile, early proof-of-concept results for twice-yearly injection are encouraging.

Read Full News

Latest News

US to Provide $50 Million More in Funding to Counter Ebola Outbreak

The U.S. plans to provide $50 million in funding to the Coalition for Epidemic Preparedness Innovations to develop ⁠medical countermeasures to target the rare strain of...

EMA Curbs Chikungunya Jab After Serious Safety Review

European regulators have restricted the chikungunya vaccine Ixchiq after serious adverse events, including neurologic events and deaths, were reported in both older and younger adults.

Congo Says 782 Ebola Cases Confirmed, Two New Health Zones Affected

The number of confirmed Ebola cases in ⁠Democratic Republic of Congo has increased to 782 after 72 ⁠new cases were documented in 24 hours, one ⁠of the biggest ‌single-day...

HIV Care Coordination Program May Reduce Deaths in NYC

New York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.

Funding Cuts Drive Sharp Drop in HIV Prevention, UNAIDS Says

Almost 40% fewer people got a drug to help prevent HIV infection in 2025 than in the previous year, as global aid funding cuts ⁠hit preventive services particularly hard,...

Organon Wins US Approval to Widen Use Of Arthritis Biosimilar Drug

Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded ⁠use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...

Todays Updates

Inside the Major Findings From the NHS-Galleri Trial

The largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.

Todays Updates

Inside the Major Findings From the NHS-Galleri Trial

The largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.

Latest News

The U.S. plans to provide $50 million in funding to the Coalition for Epidemic Preparedness Innovations to develop ⁠medical countermeasures to target the rare strain of...

European regulators have restricted the chikungunya vaccine Ixchiq after serious adverse events, including neurologic events and deaths, were reported in both older and younger adults.

The number of confirmed Ebola cases in ⁠Democratic Republic of Congo has increased to 782 after 72 ⁠new cases were documented in 24 hours, one ⁠of the biggest ‌single-day...

New York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.

Almost 40% fewer people got a drug to help prevent HIV infection in 2025 than in the previous year, as global aid funding cuts ⁠hit preventive services particularly hard,...

Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded ⁠use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...

News All Time

Romania Remains Europe’s Measles Hotspot

Romania’s children under 5 are experiencing the worst of Europe’s measles outbreaks. Are new policies sufficient to encourage more childhood vaccinations?

WHO Launches $518 Million Plan to Curb Africa Ebola Outbreak

The World Health Organization chief announced a $518 million six-month joint plan to fight Ebola on Friday, calling ⁠for money and political commitment to halt the spread of...

WHO Says Ebola Response Catching Up as Confirmed DRC Cases Hit 344

The World Health Organization said on Wednesday that the world is "catching up" with the Ebola outbreak in Democratic Republic of Congo, where there ⁠have been 344 confirmed...

Deep Dive: IL Inhibitor and JAK Inhibitor in Atopic Dermatitis

IL-4 and IL-13 drive the inflammation that breaks down the skin barrier and fuels the “atopic march” when atopic dermatitis (AD) progresses to other allergic diseases. Dupilumab blocks signaling through both pathways, delivering disease control that can persist even after treatment discontinuation in some patients.

US to Re-engage With Gavi Vaccine Alliance Amid Ebola Outbreak, Rubio Says

U.S. Secretary of State Marco Rubio said on Tuesday that the U.S. would re-engage with the global vaccine alliance Gavi amid the Ebola outbreak in several African...

Trump Signs Order to Use HHS Vaccine Assessment as Federal Guide

U.S. President Donald Trump signed an executive order to ⁠acknowledge a recent scientific assessment by the Department of Health and Human ⁠Services on childhood vaccines as...

Flesh-eating Screwworm Found Within 31 Miles of US Border, Says USDA

A devastating parasitic fly that eats warm-blooded animals alive and could cause millions of dollars in economic ⁠damage to the U.S. economy has been found in a young sheep...

US Regulator Approves Oral Drug From Japan's Shionogi to Prevent COVID-19

Japan's Shionogi & Co said on Monday ⁠the U.S. Food and Drug Administration has approved ⁠its oral antiviral Ensitrelvir, commercially known as ⁠Xocova, for the...

Deep Dive: Reducing CV Risk Beyond LDL in Secondary Prevention

The 2026 ACC/AHA Dyslipidemia Guideline has set a numerical LDL-C target for secondary prevention. Now what?

WHO Identifies Ebola Treatments & Vaccines for Testing

The World Health Organization has recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola.

FDA Advisers Recommend COVID Vaccines Be Updated to Target Current Dominant Variant

The U.S. FDA's advisory panel recommended on Thursday that COVID-19 vaccines for 2026-2027 immunization should be updated to target ⁠the dominant XFG variant, despite some...

Medicine Renamed Many Diseases: Why Rename PCOS?

The proposed PMOS terminology reframes PCOS by emphasizing the psychological, dermatologic, reproductive, and metabolic features linked to the condition.

US CDC Seeks Staff for Ebola Screening as Outbreak Response Expands

The U.S. Centers for Disease Control and Prevention has asked staff to volunteer for urgent deployment to support ⁠Ebola screening at the country's entry points, according...

mRNA Shot Offers Efficacy for Influenza-Like Illness

In older adults, a single dose of the mRNA-1010 vaccine shows superior efficacy to the standard-dose inactivated seasonal influenza vaccine in the prevention of influenza-like illness.

Red Cross Mourns Death of Three Volunteers From Ebola

The Red Cross on Saturday paid tribute to three volunteers who ⁠are believed to have died after contracting Ebola while handling bodies.

US Adds Atlanta Area Airport for Ebola Screening, CDC Says

Americans coming back from the Democratic Republic of the Congo, ⁠Uganda or South Sudan now have a second entry point for returning ⁠to the United States, with the CDC on...

Recommended News For You

Living near St. Louis-area Coldwater Creek during childhood linked with higher risk of cancer from radiation

Fitness levels for the heart and lungs are linked to a lower mortality from cancer in men.

Oleanolic acid from grapes may increase chemotherapy effectiveness

Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer

New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.

Pressing the Sleep button could have a positive impact on cognition.

Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials

Recommended Articles For You

Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery 

Neoadjuvant Radiotherapy & Endocrine Therapy in ER+ Breast Cancer Treatment 

The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies 

Unleashing the Power of AI: A Systematic Review of Predictive Biomarker Discovery in Immuno-Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

2.

Pressing the Sleep button could have a positive impact on cognition.

3.

These Medical Doctors Are Real Comedians: Should Doctors Be Funnier?

4.

Muscle Strength, Fitness Linked to Lower Mortality Risk in Patients With Cancer

5.

Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC

1.

How Cancer Cells Evade Immune Destruction and the Fight Back

2.

Exploring Innovative Approaches to Esophageal Cancer Treatment

3.

Hepatocellular Carcinoma: Emerging Trends and Innovations in Diagnosis and Management

4.

Contemporary Methods in Hematology Across Clinical Settings

5.

Uncovering New Hope for Follicular Lymphoma Patients

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

4.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

5.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot